Biodegradable polymers are expected to be an alternative to plastics. Because of its high
biocompatibility, poly (lactic-co-glycolic acid)(PLGA) is widely used in medicine. It has been …

The unique physiochemical properties of nanomaterials have been widely used in drug
delivery systems and diagnostic contrast agents. The safety issues of biomaterials with …

Recent technical innovation has enabled chemical modifications of small materials and
various kinds of nanoparticles have been created. In clinical settings, nanoparticle-mediated …

Nanoplastics (NPs) exposure is usually linked with abnormal inflammation and oxidative
stress, which are high-risk triggers of atherosclerosis; however, whether this exposure …

Among cardiovascular diseases, atherosclerosis remains the first cause of death in the
United States of America and Europe, as it leads to myocardial infarction or stroke. The high …

Targeted delivery of therapeutic agents to prevent smooth muscle cell (SMC) proliferation is
important in averting restenosis (a narrowing of blood vessels). Since platelet derived …

Vascular diseases are the leading causes of death worldwide, and they are attributable to
multiple pathologies, such as atherosclerosis, diabetes, and chronic obstructive pulmonary …

Various drug-loaded poly (lactic-co-glycolic acid)(PLGA) nanoparticles (NP) were prepared
using an emulsification/solvent evaporation technique. Different emulsion systems were …

This research aims to develop targeted nanoparticles as drug carriers to the injured arterial
wall under fluid shear stress by mimicking the natural binding ability of platelets via …

The development of a biodegradable vascular scaffold (BVS) for the treatment of
cardiovascular diseases (CVDs) still requires some improvement. Among them, re …